In vivo Safety and Immunoactivity of Oncolytic Jurona Virus in Hepatocellular Carcinoma: A Comprehensive Proteogenomic Analysis
Y. Zhang, M. Tesfay, K. U. Ferdous, M. Taylor, M. N. Gabere, C. C. Simoes, C. Dumbauld, O. Barro, A. Graham, C. L. Washam, D. Alkam, A. Gies, J. C. Chamcheu, S. D. Byrum, S. R. Post, , B. M. Nagalo
This study evaluates the in vivo safety and immunoactivity of Jurona virus in hepatocellular carcinoma using proteogenomic analysis, showing tumor regression and enhanced immune responses.
bioRxiv · Sep 9, 2022 · PreprintImmunology